Medicare Enrolled

Dr. Pedro Mego, MD

Cardiovascular Disease · Mission, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
1317 ST CLAIRE BLVD STE A5, Mission, TX 78572
9569976000
In practice since 2006 (20 years)
NPI: 1982675740 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mego from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mego? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mego

Dr. Pedro Mego is a cardiovascular disease in Mission, TX, with 20 years in practice. Based on federal Medicare data, Dr. Mego performed 1,961 Medicare services across 1,441 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mego received a total of $47,393 from 35 pharmaceutical and/or device companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mego is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 50% volume in TX$ $47,393 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,961
Medicare services
Top 50% in TX for cardiovascular disease
1,441
Unique beneficiaries
$247
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~98 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)372$59$146
Office visit, established patient (30-39 min)238$86$275
Ultrasound study of arm or leg veins with compression and maneuvers200$126$376
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes161$8$26
Ultrasound of leg arteries or artery grafts148$161$490
Electrocardiogram (EKG), 12-lead133$9$32
Ultrasound study of one arm or leg veins with compression and maneuvers122$82$236
New patient office visit (45-59 min)115$108$320
Ultrasound study of arm and leg arteries68$56$164
Ultrasonic guidance for blood vessel access62$29$89
Blood draw (venipuncture)60$8$10
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes52$37$123
Injection of chemical agent into single incompetent vein of leg using ultrasound guidance37$919$2,936
Injection of chemical agent into multiple incompetent veins of same leg using ultrasound guidance34$1,016$3,006
Review by radiologist of abdominal aorta and both leg arteries image30$120$416
New patient office visit (30-44 min)26$72$210
Removal of plaque in arteries of leg22$5,484$27,418
Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance21$771$2,660
Removal of plaque in artery of leg, initial vessel18$6,595$27,525
Review by radiologist of additional artery image16$74$262
Balloon dilation of artery of leg, initial vessel13$2,147$12,008
Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts13$130$364
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
32.1% medium
67.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$47,393
Total received (2018-2024)
Avg $6,770/year across 7 years
Top 11% in TX for cardiovascular disease
35
Companies
319
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$26,871 (56.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,001 (40.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,521 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,063
2023
$2,167
2022
$1,107
2021
$1,501
2020
$1,228
2019
$13,970
2018
$26,356

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bard Peripheral Vascular, Inc.
$15,408
BARD PERIPHERAL VASCULAR, INC.
$9,988
Philips Electronics North America Corporation
$4,464
Cardiovascular Systems Inc.
$4,317
BIOTRONIK INC.
$2,132
C. R. Bard, Inc. & Subsidiaries
$1,600
Medtronic Vascular, Inc.
$1,343
Boston Scientific Corporation
$1,288
ARALEZ PHARMACEUTICALS US INC.
$1,271
Janssen Pharmaceuticals, Inc
$838
Abbott Laboratories
$821
Medtronic, Inc.
$682
BOSTON SCIENTIFIC CORPORATION
$543
Tactile Systems Technology Inc
$461
PFIZER INC.
$300
Terumo Medical Corporation
$250
Novartis Pharmaceuticals Corporation
$238
Amgen Inc.
$206
Cardinal Health 200 LLC
$202
AstraZeneca Pharmaceuticals LP
$192
Sechrist Industries Inc
$155
ABIOMED
$127
Veryan Medical Incorporated
$114
Melinta Therapeutics, LLC
$107
Philips North America LLC
$69
E.R. Squibb & Sons, L.L.C.
$43
Averitas Pharma Inc.
$38
Novo Nordisk Inc
$35
ABBVIE INC.
$34
CeloNova BioSciences, Inc.
$26
Regeneron Healthcare Solutions, Inc.
$24
Gilead Sciences, Inc.
$23
SANOFI-AVENTIS U.S. LLC
$20
Cook Medical LLC
$18
Esperion Therapeutics, Inc.
$14
Top 3 companies account for 63.0% of total payments
Associated products mentioned in payments ›
(4066) Tack Endovascular Systems ATK · (6554) Periph Vasc Undiv · (6554) Peripheral Vascular Undivided · (9281) Turbo Elite · (9520) IGT Devices Undivided · (DD1) Duo Hybrid · ACCOLADE · ANGIOJET · Acculink carotid stent system · Acticor · Assurity Pacemaker · BRILINTA · BioMimics 3D Vascular Stent System · CHANTIX · COREVALVE EVOLUT R · CROSSER · ClosureFast · Connectivity and Remote care · CoreValve Evolut · Coronary Orbital Atherectomy System · DALVANCE · DIAMONDBACK PERIPHERAL · Diamondback Coronary · Diamondback Peripheral · ELIQUIS · ELUVIA · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENTRESTO · Ellipse ICD · Etrinsa · FARXIGA · Flexitouch Plus · Fortify Assura · GENERAL VASCULAR INTERVENTION · GENERAL ULTRASOUND · GENERAL VASCULAR INTERVENTION · GENERAL - VASCULAR INTERVENTION · GENERAL PAIN MANAGEMENT · General - Vascular Intervention · Glidesheath · HAWKONE · IGT D Peripheral · IGT_D Peripheral · IGT_D Therapy · IVUS Systems · Impella · Kimyrsa · LEQVIO · LOKELMA · LUTONIX · LUTONIX Drug Coated Balloon · MYNX CONTROLTM · NEXLETOL · OPTEASE Retrievable Vena Cava Filter · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · QUTENZA · Repatha · Supera peripheral stent system · Turbo Power · ULTRASCORE · VENOVO · Varithena Administration Pack · VenaSeal · XARELTO · ZILVER VENA · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (57%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.

Equivalent to $2,417 per 100 Medicare services performed
Looking for a cardiovascular disease in Mission?
Compare cardiovascular diseases in the Mission area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
34
Per 100K population
3.9
County median income
$52,281
Nearest hospital
MISSION REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mego is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 11%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mego experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mego performed 372 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mego receive payments from pharmaceutical companies?
Yes. Dr. Mego received a total of $47,393 from 35 companies across 319 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mego's costs compare to other cardiovascular diseases in Mission?
Dr. Mego's average Medicare payment per service is $247. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mego) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →